RNA, 5S ribosomal pseudogene 521 (RNA5SP521)

RNA, 5S ribosomal pseudogene 521 is classified as an rRNA pseudogene in the human genome[2][4][5]. Pseudogenes are genetic elements arising from gene duplication or retrotransposition events, but are rendered non-functional by mutations or deletions[8]. RNA5SP521 is annotated in human genomic databases as a noncoding, non-functional derivative of the 5S ribosomal RNA gene and does not participate in ribosomal structure or protein synthesis. Unlike functional 5S rRNA, which plays a key structural and regulatory role in ribosome assembly and allosteric communication within the ribosome[1][3][7], pseudogenes like RNA5SP521 lack biological activity and are not involved in known cellular processes or disease mechanisms. As a pseudogene, RNA5SP521 is not considered a therapeutic target, biomarker, or drug interaction partner. Its presence is primarily used for genomic mapping and evolutionary studies and carries no safety, biomarker, or mechanistic relevance for molecular medicine or drug development. The gene record is likely listed principally for annotation completeness; "RNA, 5S ribosomal pseudogene 521" is not a receptor, enzyme, transporter, or any known therapeutic target. The query is likely incorrect in context of drug target databases or translational research[2][4][5][8].

Other names

RN5S521RNA, 5S ribosomal 521RNA5SP521